Corepath Wealth Partners’s Aurora Cannabis ACB Stock Holding History

Corepath Wealth Partners’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,928	Closed	-$169K	–	37
2021 Q4	$169K	Buy	+2,928	New	+$197K	0.12%	40

Other funds holding ACB

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Corepath Wealth Partners's ACB Position: Q1 2022 in Review

Corepath Wealth Partners sold out of Aurora Cannabis (ACB) in Q1 2022, closing a stake of 2,928 shares — an estimated $169K sold.

Corepath Wealth Partners first reported a position in ACB in Q4 2021 and held it in 1 quarter. The position peaked at $169K in Q4 2021. 253 funds tracked by Wall St. Rank hold ACB as of Q1 2022.

Corepath Wealth Partners reported no remaining Aurora Cannabis position as of Q1 2022 after selling out during the quarter.
Corepath Wealth Partners sold 2,928 Aurora Cannabis shares in Q1 2022, an estimated $169K.
Corepath Wealth Partners first reported a position in Aurora Cannabis in Q4 2021 and held it in 1 quarter.
Corepath Wealth Partners's Aurora Cannabis position peaked at $169K in Q4 2021.
253 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2022.

Based on Corepath Wealth Partners's 13F filing for Q1 2022, filed 9 May 2022.